[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509669":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":61,"collaborators":64,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":10,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Emory University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"General Population Screening Cohort",null,"A general population cohort of 9-month-old infants presenting for well-child visits will be screened initially at 9 months of age, and then screened again sequentially at 12, 15, 18, 21, and 24 months, to test screening performance relative to outcome status with autism or developmental disabilities.",[13],"Diagnostic Test: EarliPoint Investigational Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","EarliPoint Investigational Device","Infants will complete eye-tracking data collection at the age of 9 months on the EarliPoint Investigational Device. Eye-tracking video cameras will safely measure the movements of the child's eyes while they watch age-appropriate video scenes of other children playing together. Parents\u002FCaregivers will complete screening forms and questionnaires about their baby's health and development. Parents\u002Fcaregivers will complete surveys about their child's development. The surveys will be emailed, to be completed when the child is approximately 9, 12, 15, 18, 21, and 24 months old. If the child shows signs of developmental delay, the child will be asked to participate in a comprehensive developmental and diagnostic assessment.",[9],[21],"Screening test",[23],{"name":24,"affiliation":5,"role":25},"Warren R Jones, PhD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"FirstFocus Study","CONTACT","404-785-4529","FirstFocus@emory.edu",[33,53],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Children's Healthcare of Atlanta","RECRUITING","Atlanta","Georgia","30322","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-84.38798,33.749,{"lat":45,"lon":44},[48,49],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"name":50,"role":29,"phone":51,"phoneExt":10,"email":52},"Cheryl Klaiman, PhD","404-785-9387","cklaima@emory.edu",{"facility":5,"status":35,"city":36,"state":37,"zip":54,"country":39,"countryCode":40,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"30329",{"type":42,"coordinates":56},[44,45],{"lat":45,"lon":44},[59,60],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"name":50,"role":29,"phone":51,"phoneExt":10,"email":52},{"type":25,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Warren R. Jones","Associate Professor",[65],{"name":66,"class":67},"National Institute of Mental Health (NIMH)","NIH","100509669","screening-for-autism-in-9-month-olds-by-measuring-social-visual-engagement-100509669",false,"NCT05916430","Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement","Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement","Inclusion Criteria:\n\n* Infants between the chronological ages of 8-10 months\n* Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision)\n* Participants' parents\u002Fcaregivers must be able to understand and voluntarily provide written informed consent.\n\nExclusion Criteria:\n\n\\- Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).",true,"ALL","8 Months","10 Months",{"count":80,"type":81},2120,"ESTIMATED","OBSERVATIONAL","The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.",[85,86],"Autism","Infant Development",[88,89,90,91,92,93],"Screening","well-baby visits","Social Development","Communicative Development","Development Disabilities","Autism Spectrum Disorders","2026-06-02",{"date":96,"type":97},"2026-06-04","ACTUAL",{"date":99,"type":97},"2023-02-02",{"date":101,"type":81},"2027-12",{"name":5,"class":6},2]